Net Cash Provided by (Used in) Operating Activities |
-216K |
USD |
+40.6% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
244K |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
34M |
USD |
|
Q1 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
2.5M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6.33K |
USD |
-21.4% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
689K |
USD |
+123% |
Q4 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2024 |
Q2 2024 |
Cash and Cash Equivalents, Period Increase (Decrease) |
-156K |
USD |
-1456% |
Q1 2022 |
Q1 2022 |
Deferred Tax Assets, Gross |
689K |
USD |
+123% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
0 |
USD |
-100% |
Q4 2022 |
FY 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-110K |
USD |
|
Q1 2022 |
Q1 2022 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
0 |
USD |
|
Q1 2022 |
Q1 2022 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Current State and Local Tax Expense (Benefit) |
0 |
USD |
|
Q1 2022 |
Q1 2022 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Q1 2022 |
Q1 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2022 |
Q1 2022 |
Deferred State and Local Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2022 |
Q1 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |